Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease
SensiCare
Evaluation of the Impact of Care Based on Sensory Support for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease
2 other identifiers
interventional
31
1 country
1
Brief Summary
The main objective of this study is to evaluate the effect of 3 months of "Snoezelen-type" multi-sensory care sessions on NeuroPsychiatric Inventory Questionnaire (NPI-Q) scores for patients with Alzheimer's-type neurodegenerative disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable alzheimer-disease
Started Jun 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2013
CompletedFirst Posted
Study publicly available on registry
March 28, 2013
CompletedStudy Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedApril 29, 2015
April 1, 2015
11 months
March 25, 2013
April 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in NPI-Q scores
3 months
Secondary Outcomes (12)
Change from baseline in NPI-Q scores
1 month
Change from baseline in NPI-Q scores
6 months
Change from baseline in NPI-Q scores
12 months
Change from baseline in the Quality-of-life-Alzheimer's Disease questionnaire (QOL-AD)
12 months
Change from baseline in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire
1 month
- +7 more secondary outcomes
Study Arms (1)
Study population
EXPERIMENTALPatients hospitalized at the Serre-Cavalier centre and who have Alzheimer's-type neurodegenerative disease (see inclusion criteria).
Interventions
The Serre-Cavalier center will implement Snoezelen-type multisensory care sessions for included patients; these care sessions correspond with the patients' daily hygiene/toilette care. The impact of this multisensory strategy will be evaluated using a before-after design.
Eligibility Criteria
You may qualify if:
- The patient's legal representative must have given his/her informed and signed consent (or the patient if he/she is judged competent)
- The patient must be insured or beneficiary of a health insurance plan
- Alzheimer's-type neurodegenerative pathology
- The patient has been living in the participating center for \> 2 months
You may not qualify if:
- The patient's legal representative refuses to sign the consent (or the patient if he/she is judged competent)
- It is impossible to correctly inform the patient's legal representative
- The patient has already has Snoezelen-therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nîmes - Centre de Gérontologie de Serre Cavalier
Nîmes, 30029, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jane Debuysschere, IDE
Centre Hospitalier Universitaire de Nîmes
- PRINCIPAL INVESTIGATOR
Jean-Marie Cros, MD
Centre Hospitalier Universitaire de Nîmes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2013
First Posted
March 28, 2013
Study Start
June 1, 2013
Primary Completion
May 1, 2014
Study Completion
February 1, 2015
Last Updated
April 29, 2015
Record last verified: 2015-04